Approval · Notice of Compliance 27854 · 2022
QINLOCK: Notice of Compliance 27854
Issued March 30, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27854
- Date
- March 30, 2022
- Company
- Deciphera Pharmaceuticals. LlcWaltham, Massachusetts, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of manufacturing site, Hovione Pharma, Portugal.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QINLOCK | Not yet assigned | — |
Medicinal ingredients
- RIPRETINIB 50 MG per TAB